Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.

Source:http://linkedlifedata.com/resource/pubmed/id/21707707

Download in:

View as

General Info

PMID
21707707